Immucell Corp (ICCC) Reports Q4 EPS of $0.06
Tweet
Share
E-mailGet Alerts ICCC Hot Sheet
Price: $9.87 +1.33%
Financial Fact:
Product development expenses: 307.72K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Financial Fact:
Product development expenses: 307.72K
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Immucell Corp (NASDAQ: ICCC) reported Q4 EPS of $0.06. Revenue for the quarter came in at $7.8 million.
For earnings history and earnings-related data on Immucell Corp (ICCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Axis Capital Limited Upgrades Tata Elxsi Ltd (TELX:IN) to Buy (1)
- Axis Capital Limited Upgrades Zensar Technologies Ltd. (ZENT:IN) to Buy (1)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
